A

Abeona Therapeutics
D

ABEO

6.55000
USD
0.07
(1.00%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
7
حجم السوق
373,318,193
أصول ذات صلة المقالات
المزيد

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.